UCLA: Attacking metastatic prostate cancer early with combination treatment improves outcomes

Caius Radu, Christine Mona, Amar Kishan, Beth Glenn, Mina Sedrak, William Lowry named program leaders at UCLA Health Jonsson CCC

Top row (left to right): Caius Radu, Amar Kishan and Christine Mona. Bottom row (left to right): Beth Glenn, Mina Sedrak and William Lowry. The UCLA Health Jonsson Comprehensive Cancer Center has appointed new leadership to several of its programs.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows

The Decipher Prostate Genomic Classifier predicts which patients with metastatic cancer are likely to benefit from treatment intensification with the chemotherapy docetaxel and which are not likely to benefit and can therefore avoid unnecessary toxicity, according to findings by University College London and Veracyte, Inc., a genomic diagnostic company.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Many patients with advanced cancer feel treatment not aligned with personal care goals, UC study shows

Many people with advanced cancer report that their treatment does not align with their personal care goals, according to a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and the UCLA Palliative Care Research Center.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Mailing at-home test kits is more effective at getting younger adults to participate in CRC screening, UCLA study finds

Mailing a stool-based test directly to people’s homes was the most effective of four strategies for increasing colorectal cancer screening rates, according to a study by UCLA researchers aimed at identifying the best approach to promote CRC screening in adults ages 45 to 49.

August 08, 2025

Vol.51 No.31

In Brief

UIC, Northwestern, Moffitt researchers awarded $1.2M DOD grant for prostate cancer research

The U.S. Department of Defense Prostate Cancer Research Program has awarded the Data Science Award and a $1.2 million grant to researchers Charles Gaber, Natalie Reizine, Todd Lee, Lucia Petito, and Jessica Islam.

August 01, 2025

Vol.51 No.30

Clinical Roundup

Blood tests show potential for CRC detection, but follow-up falls short

About half patients completed a follow-up colonoscopy within six months of taking a blood-based colorectal cancer screening test, according to a study by investigators at UCLA Health Jonsson Comprehensive Cancer Center.

August 01, 2025

Vol.51 No.30

UCLA: Attacking metastatic prostate cancer early with combination treatment improves outcomes

YOU MAY BE INTERESTED IN

Caius Radu, Christine Mona, Amar Kishan, Beth Glenn, Mina Sedrak, William Lowry named program leaders at UCLA Health Jonsson CCC

Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows

Many patients with advanced cancer feel treatment not aligned with personal care goals, UC study shows

Mailing at-home test kits is more effective at getting younger adults to participate in CRC screening, UCLA study finds

UIC, Northwestern, Moffitt researchers awarded $1.2M DOD grant for prostate cancer research

Blood tests show potential for CRC detection, but follow-up falls short

Renew today!

Subscriber content

Never miss an issue!

Login